« Return to News | CROs/Service Providers

SpringFire adds Atherotech Diagnostics to its network

Tuesday, July 26, 2011 12:30 PM

SpringFire Laboratory Network has reported the addition of Atherotech Diagnostics Lab to its network of affiliate laboratories, which provides specialized testing services to clinical trial sponsors and CROs.

The agreement adds Atherotech’s cardiometabolic testing services, including the patented VAP (Vertical Auto Profile) advanced lipid profile, to SpringFire’s offering.

Jim McClintic, managing partner of SpringFire Laboratory Network, said high complexity laboratories such as Atherotech are in great demand in the clinical trials market. They offer rapid turnaround times, competitive pricing and professional consultation on protocol development with clinical trials experience.

Atherotech offers researchers more than 50 cardiovascular and metabolic tests and is the only laboratory that performs the VAP Cholesterol Test, a directly measured assessment of all major lipoprotein classes (HDL, LDL, VLDL, IDL and Lp(a)) and their important subclasses, including HDL2, HDL3, LDL1-LDL4, apoB, apoA1 and the apoB/apoA1 ratio. The VAP profile also provides LDL subclass pattern (A, A/B or B) and remnant lipoprotein cholesterol.

“This partnership will further expose the VAP Test to the clinical trial marketplace,” said Michael Mullen, CEO of Atherotech.

With a combined menu of more than 1,000 specialty tests, SpringFire offers sponsors and CROs expertise and testing services in numerous therapeutic areas, including anatomical pathology, molecular genetics and women’s health.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.